A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Challenges, Insights and Outcomes of a Clinically Integrated Multi-omic Rare Disease Program, RDNow, for Individuals Who Remain Undiagnosed After Clinical Genomic Sequencing Thursday, October 26 | 7 a.m. ET | Online Speaker: Dr. Michelle de Silva Michelle is an associate genetic counselor with a PhD in molecular genetics. She is an experienced medical researcher and […]
International Conference for Genomic Medicine 2026 January 21 – 22 | Riyadh, Saudi Arabia ICGM 2026 is an international scientific conference that will convene leading minds in genomics, multi-omics, and artificial intelligence to explore the frontiers of next-generation healthcare. With the theme “Next Generation MultiOmics: The AI Revolution,” the event will showcase how AI is […]
GMKB